A prospective study on the safety of sublingual immunotherapy in pregnancy

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 67, Issue 6, 2012, Pages 741-743

  Shaikh, W A ^a   Shaikh, S W ^a  

^a Allergy and Asthma Clinic   (India)

Author keywords

immunotherapy; pregnancy; safety; Sublingual

Indexed keywords

ALLERGEN; BUDESONIDE; CETIRIZINE; HOUSE DUST ALLERGEN; POLLEN ANTIGEN; SALBUTAMOL;

ABORTION; ADULT; ARTICLE; ASTHMA; CONGENITAL MALFORMATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LIP DISEASE; LIP SWELLING; MAJOR CLINICAL STUDY; MOUTH CAVITY PRURITUS; MOUTH DISEASE; NEWBORN DEATH; PERINATAL DEATH; PREGNANCY; PREGNANCY COMPLICATION; PREGNANT WOMAN; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; RHINITIS; SUBLINGUAL IMMUNOTHERAPY; SWELLING; TOXEMIA; TREATMENT OUTCOME;

ADMINISTRATION, SUBLINGUAL; ADULT; ALBUTEROL; ALLERGENS; BRONCHODILATOR AGENTS; BUDESONIDE; DESENSITIZATION, IMMUNOLOGIC; FEMALE; FETUS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; YOUNG ADULT;

EID: 84861098045     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2012.02815.x     Document Type: Article

References (15)

1. Noon L,. Prophylactic inoculation against hay fever. Lancet 1911; 1: 1572-1573.
2. Passalaqua G., Canonica GW,. Specific Immunotherapy in asthma: efficacy and safety. Clin Exp Allergy 2011; 41: 1247-1255.
3. Bousquet J, Khaltaev R, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic rhinitis and its impact on asthma. Allergy 2008; 63 (Suppl): 8-160.
4. Blaiss MS,. Management of rhinitis and asthma in pregnancy. Ann Allergy Asthma Immunol 2003; 90: 16-22.
5. Metzger WJ, Turner E, Patterson R,. The safety of immunotherapy during pregnancy. J All Clin Immunol 1978; 61: 268-272.
6. Shaikh WA,. A retrospective study on the safety of immunotherapy during pregnancy. Clin Exp Allergy 1993; 23: 857-860.
7. Scadding, Brostoff J,. Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite. Clin Allergy 1986; 16: 483-491.
8. Canonica GW,. Sublingual immunotherapy: World Allergy Organisation Position Paper. WAO J 2009; 2: 233-281.
9. Babu NP, Nidhi D, Verma KR,. Abortion in India: what does the National Family Health Survey tell us. J Family Welfare 1998; 44: 45-54.
10. Pallikadavath S, Stones RW,. Miscarriage in India: a population based study. Fertil Ster 2005; 84: 516-518.
11. Kumar D, Verma A, Sehgal VK,. Neonatal mortality in India. Rural Remote Health 2007; 7: 833.
12. Bang AT, Baitule SB, Reddy HM, Deshmukh MD, Bang RA,. Low birth weight and preterm neonates. J Neonatol 2005; 25: s72-s81.
13. Patel ZM, Adhia RA,. Birth defects surveillance study. Ind J Paed 2005; 72: 489-491.
14. Dhall K,. Epidemiology of Preeclampsia and eclampsia. Asia-Oceania J Obs Gyn 1984; 10: 89-93.
15. Shaikh WA, Shaikh SW,. Allergies in India: an analysis of 3389 patients attending an allergy clinic in Mumbai, India. J Indian Med Assoc 2008; 106: 220-224.